'Remote Pharmacy logo with a white cross symbol on a black background.'

QUESTIONS? CALL OR TEXT US AT 435-351-2380

Monday - Sunday: 8:00am- 8:00pm EST

Two Wegovy semaglutide injection pens on a white background.

Wegovy®

$1672/month

$0
  • Lose up to 15% of body weight.1

  • FDA-approved for weight loss

  • Once-weekly semaglutide injections with convenient, pre-measured pens

  • Feel full faster, reduce cravings, and regulate appetite

Details

Active ingredients

How to Use ?

Why Remote Pharmacy ?

*This medication is only available with a prescription following an online consultation with a licensed healthcare provider. Wegovy® is an FDA-approved medication for weight loss, backed by clinical studies. Results may vary. Actual product packaging may vary from the images shown. For additional information, see https://www.wegovy.com/. Physicians may prescribe compounded medications to address patient needs or drug shortages. While compounded drugs are permitted under federal law, they are not FDA-approved or evaluated for safety, efficacy, or quality by FDA.

Key Benefits of GLP-1s

Woman smiling at smartphone on top, two healthcare professionals smiling below.

Appetite Suppressant

GLP-1 medications target the brain's appetite-regulating centers, helping to reduce food cravings, control hunger, and reduce overall caloric intake.

Prolonged Fullness

These GLP-1 medications help slow down stomach emptying, which provides a lasting feeling of fullness and helps prevent overeating.

Long-Term Efficacy

Studies have demonstrated that GLP-1 medications are an effective tool for losing weight and maintaining the results for over a year.

Significant Weight Loss

Clinical trials found that people using GLP-1 medications lost an average of 15% of their body weight.*

15%

On average, patients on semaglutide lost 15% of their body weight.*

Select your current weight (lbs):
270lbs

Weight you may lose (lbs):

40lbs

*In a 68-week clinical trial studying once-weekly semaglutide (2.4mg) in patients without diabetes and with BMI ≥30, or BMI ≥27 with a weight-related condition, the average weight loss was 15% when paired with lifestyle intervention (compared to 2.4% with lifestyle intervention alone).1

Start Losing Weight in 3 Steps

1

Health Questionnaire

Answer a few questions to help us understand your health concerns and medical history.

2

Doctor Approval

A licensed U.S. physician will review your information and determine your eligibility to create a personalized treatment plan.

3

Fast

Delivery

Once approved, our partner pharmacy will process your prescription and ship your medication within as little as 3 days.

Ready to lose weight?

See if I qualify

A few reviews from real patients

Just pay for your medication

What's included

No surprise bills or extra fees.

Physician consultation

GLP-1 Prescription (if appropriate)

Fast, free shipping

Ongoing care & support

24/7 customer service

Start Your Journey

The image is not displaying content; it appears to be a broken image link or an error icon.

Read All FAQ

QUESTIONS? CALL OR TEXT US AT 435-351-2380

Monday - Sunday: 8:00am- 8:00pm EST

See if I qualify

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England journal of medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183